NCT Number: NCT02722824
Efficacy of a Non-invasive Device for Alleviation of Parkinson's Disease Symptoms
Investigation efficacy of a non-invasive wearable electrostimulator device where the supplementary motor area, premotor area and/or subthalamic nucleus are stimulated bilaterally and extracranially.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Istanbul University, Istanbul, Turkey (Türkiye)
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Diagnosis of Parkinson's Disease
- H&Y Stage >= 2
- Existing bradykinesia symptoms
- Existence of one of the symptoms below
- Resting Tremor
- Rigidity
- Walking disorder
Exclusion criteria
- Cardiac Pacemaker
- Psychiatric diagnosis
- Irregular heart/respiration rate
- Pregnancy
- Alcohol consumption
- Cardiovascular disease history
- Wearing an electro-active prosthesis
- Brain surgery history
- Ongoing TENS/PENS therapy
Treatment and study plan
Placebo
OtherPrimary outcomes
-
Change in the UPDRS Motor Score (Part III)
Time frame: 10 minutes after the stimulation is initiated.
Evaluation of patients' disease level with UPDRS examination at the middle of the stimulation
-
Change in the UPDRS Motor Score (Part III)
Time frame: 30 minutes after the stimulation is terminated.
Evaluation of patients' disease level with UPDRS examination 30 minutes after the stimulation is terminated.
Secondary outcomes
-
Change in the gait and balance parameters (cadence)
Time frame: 10 minutes after the stimulation is initiated.
cadence
-
Change in the gait and balance parameters (Stride length)
Time frame: 10 minutes after the stimulation is initiated.
Stride length in meters
-
Change in the gait and balance parameters (Stride velocity)
Time frame: 10 minutes after the stimulation is initiated.
Stride velocity in m/s
-
Change in the gait and balance parameters
Time frame: 10 minutes after the stimulation is initiated.
Arm Swing Rate
-
Change in the gait and balance parameters
Time frame: 10 minutes after the stimulation is initiated.
Arm Range of Motion
-
Change in the gait and balance parameters
Time frame: 10 minutes after the stimulation is initiated.
Sit to Stand Duration
-
Change in the gait and balance parameters
Time frame: 10 minutes after the stimulation is initiated.
Sit to Stand Peak Trunk Velocity
-
Change in the gait and balance parameters
Time frame: 10 minutes after the stimulation is initiated.
Sit to Stand Peak Trunk Angle
-
Change in the gait and balance parameters
Time frame: 10 minutes after the stimulation is initiated.
Leg Swing Rate
-
Change in the gait and balance parameters
Time frame: 10 minutes after the stimulation is initiated.
Leg Range of Motion
-
Change in the gait and balance parameters
Time frame: 10 minutes after the stimulation is initiated.
Turn to Sit Peak Turn Velocity
-
Change in the gait and balance parameters
Time frame: 10 minutes after the stimulation is initiated.
Turn-to-Sit Trunk Range of Motion in Sagittal Plane
-
Change in the gait and balance parameters
Time frame: 10 minutes after the stimulation is initiated.
Knee Range of Motion
-
Change in the gait and balance parameters
Time frame: 10 minutes after the stimulation is initiated.
Trunk Joint Angles
-
Change in the gait and balance parameters (cadence)
Time frame: 30 minutes after the stimulation is terminated.
cadence
-
Change in the gait and balance parameters (Stride length)
Time frame: 30 minutes after the stimulation is terminated.
Stride length in meters
-
Change in the gait and balance parameters (Stride velocity)
Time frame: 30 minutes after the stimulation is terminated.
Stride velocity in m/s
-
Change in the gait and balance parameters
Time frame: 30 minutes after the stimulation is terminated.
Arm Swing Rate
-
Change in the gait and balance parameters
Time frame: 30 minutes after the stimulation is terminated.
Arm Range of Motion
-
Change in the gait and balance parameters
Time frame: 30 minutes after the stimulation is terminated.
Sit to Stand Duration
-
Change in the gait and balance parameters
Time frame: 30 minutes after the stimulation is terminated.
Sit to Stand Peak Trunk Velocity
-
Change in the gait and balance parameters
Time frame: 30 minutes after the stimulation is terminated.
Sit to Stand Peak Trunk Angle
-
Change in the gait and balance parameters
Time frame: 30 minutes after the stimulation is terminated.
Leg Swing Rate
-
Change in the gait and balance parameters
Time frame: 30 minutes after the stimulation is terminated.
Leg Range of Motion
-
Change in the gait and balance parameters
Time frame: 30 minutes after the stimulation is terminated.
Turn-to-Sit Peak Turn Velocity
-
Change in the gait and balance parameters
Time frame: 30 minutes after the stimulation is terminated.
Turn-to-Sit Trunk Range of Motion
-
Change in the gait and balance parameters
Time frame: 30 minutes after the stimulation is terminated.
Knee Range of Motion
-
Change in the gait and balance parameters
Time frame: 30 minutes after the stimulation is terminated.
Trunk Joint Angles
Sponsors and collaborators
Lead sponsor
Koç University
Other
Collaborators
- Istanbul University
Registry information
Official study title
Efficacy Investigation of a Non-invasive Wearable Electrostimulation Device for Alleviation of Parkinson's Disease Symptoms
Important dates
- Study start
- 2015
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Mar 30, 2016
- Registry last updated
- Jul 26, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Clinical Laboratory Evaluation of Chronic Autonomic Failure
NCT03648905
Autonomic Failure, Autonomic Nervous System Diseases
Bethesda, Maryland, United States
View Trial DetailsAAV2-GDNF for Advanced Parkinson s Disease
NCT01621581
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsPre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
NCT05699460
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Irvine, California, United States
View Trial DetailsEffects of Wild Blueberry Ingestion on Motor Performance of People With Parkinson's Disease
NCT07720869
Basal Ganglia Diseases, Brain Diseases
Baton Rouge, Louisiana, United States
View Trial Details